Kintara Therapeutics, Inc.(KTRA)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

KTRA Kintara Therapeutics, Inc.

盘后交易 11-22 19:27:37 EST

7.54

+0.00

0.00%

最高7.54	最低7.54	成交量0.00
今开7.54	昨收7.54	日振幅0.00%
总市值4.20亿	流通市值4.19亿	总股本5,566万
成交额80.33万	换手率0.00%	流通股本5,559万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"KTRA","market":"US","secType":"STK","nameCN":"Kintara Therapeutics, Inc.","latestPrice":7.539,"timestamp":1729195200000,"preClose":7.539,"halted":8,"volume":0,"delay":0,"floatShares":55592065,"shares":55660578,"eps":-0.322594,"marketStatus":"盘后交易","marketStatusCode":4,"change":0,"latestTime":"11-22 19:27:37 EST","open":7.539,"high":7.539,"low":7.539,"amount":803285.264224,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.322594,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1732323600000},"symbolChange":{"newSymbol":"HURA","executeDate":"2024-10-18"},"adr":0,"adjPreClose":7.539,"volumeRatio":0},"requestUrl":"/m/hq/s/KTRA/tweets","defaultTab":"tweets","newsList":[{"id":"2475910253","title":"Kintara Therapeutics, Inc.盘中异动 临近午盘急速上涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475910253","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475910253?lang=zh_cn&edition=full","pubTime":"2024-10-16 23:43","pubTimestamp":1729093393,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日23时43分，Kintara Therapeutics, Inc.股票出现波动，股价大幅拉升5.02%。Kintara Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.44%。其相关个股中，180 Life Sciences Corp.、Korro Bio, Inc.、Quoin Pharmaceuticals Ltd涨幅较大，180 Life Sciences Corp.、Biodexa Pharmaceuticals Plc、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为6212.38%、1091.10%、777.16%，振幅较大的相关个股有180 Life Sciences Corp.、180 Life Sciences Corp C/Wts 07/11/2025、Korro Bio, Inc.，振幅分别为633.55%、279.52%、126.58%。Kintara Therapeutics, Inc.公司简介：Kintara Therapeutics Inc从事针对医疗需求未得到满足的患者的新型癌症疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016234313ab6a930c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016234313ab6a930c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","DMPWW","KTRA"],"gpt_icon":0},{"id":"2475568223","title":"Kintara Therapeutics, Inc.盘中异动 股价大涨5.10%报0.208美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475568223","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475568223?lang=zh_cn&edition=full","pubTime":"2024-10-15 22:34","pubTimestamp":1729002861,"startTime":"0","endTime":"0","summary":"北京时间2024年10月15日22时34分，Kintara Therapeutics, Inc.股票出现波动，股价快速上涨5.10%。Kintara Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.33%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Psyence Biomedical Ltd C/Wts 25/01/2029、Apollomics Inc C/Wts 01/04/2028 涨幅较大，Lipella Pharmaceuticals Inc.、Gritstone Bio, Inc.、Enveric Biosciences, Inc.较为活跃，换手率分别为300.75%、194.88%、183.55%，振幅较大的相关个股有Apollomics Inc C/Wts 01/04/2028 、Gritstone Bio, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为85.94%、33.15%、28.45%。Kintara Therapeutics, Inc.公司简介：Kintara Therapeutics Inc从事针对医疗需求未得到满足的患者的新型癌症疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241015223421ab6a47ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241015223421ab6a47ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","KTRA","DMPWW","BK4139"],"gpt_icon":0},{"id":"2473105601","title":"Kintara Therapeutics, Inc.盘中异动 股价大跌5.17%报0.200美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473105601","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473105601?lang=zh_cn&edition=full","pubTime":"2024-10-07 21:31","pubTimestamp":1728307884,"startTime":"0","endTime":"0","summary":"北京时间2024年10月07日21时31分，Kintara Therapeutics, Inc.股票出现波动，股价快速下挫5.17%。截至发稿，该股报0.200美元/股，成交量15.4186万股，换手率0.28%，振幅0.00%。Kintara Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。Kintara Therapeutics, Inc.公司简介：Kintara Therapeutics Inc从事针对医疗需求未得到满足的患者的新型癌症疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100721312498e3ad70&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100721312498e3ad70&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DMPWW","KTRA","BK4139","LENZ"],"gpt_icon":0},{"id":"2471383315","title":"Kintara Therapeutics, Inc.盘中异动 急速下跌5.13%报0.194美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2471383315","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471383315?lang=zh_cn&edition=full","pubTime":"2024-09-30 21:30","pubTimestamp":1727703044,"startTime":"0","endTime":"0","summary":"北京时间2024年09月30日21时30分，Kintara Therapeutics, Inc.股票出现波动，股价快速下挫5.13%。Kintara Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Estrella Immunopharma Inc C/Wts 29/09/2028、Prime Medicine, Inc.、Aeon Biopharma, Inc.涨幅较大，Aditxt, Inc.、Windtree Therapeutics, Inc.、Onconetix, Inc.较为活跃，换手率分别为24.08%、16.89%、13.72%，振幅较大的相关个股有Century Therapeutics, Inc.、Igc Pharma, Inc.、Lineage Cell Therapeutics, Inc.，振幅分别为9.32%、3.87%、3.14%。Kintara Therapeutics, Inc.公司简介：Kintara Therapeutics Inc从事针对医疗需求未得到满足的患者的新型癌症疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240930213045ab67270a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240930213045ab67270a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KTRA","BK4139","LENZ","DMPWW"],"gpt_icon":0},{"id":"2469211486","title":"Kintara Therapeutics, Inc.盘中异动 早盘急速下跌5.69%报0.164美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469211486","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469211486?lang=zh_cn&edition=full","pubTime":"2024-09-23 21:32","pubTimestamp":1727098360,"startTime":"0","endTime":"0","summary":"北京时间2024年09月23日21时32分，Kintara Therapeutics, Inc.股票出现异动，股价大幅下挫5.69%。Kintara Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。其相关个股中，Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Cingulate Inc C/Wts 10/12/2026 、Pharmacyte  Biotech, Inc.涨幅较大，Galmed Pharmaceuticals Ltd.、Black Diamond Therapeutics, Inc.、Scisparc Ltd.较为活跃，换手率分别为41.98%、26.22%、22.64%，振幅较大的相关个股有Pharmacyte  Biotech, Inc.、Galmed Pharmaceuticals Ltd.、天演药业，振幅分别为18.52%、16.05%、13.14%。Kintara Therapeutics, Inc.公司简介：Kintara Therapeutics Inc从事针对医疗需求未得到满足的患者的新型癌症疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240923213240a1dbec3b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240923213240a1dbec3b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","KTRA","DMPWW","BK4139"],"gpt_icon":0},{"id":"2468462181","title":"Kintara Therapeutics, Inc.盘中异动 大幅下挫5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468462181","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468462181?lang=zh_cn&edition=full","pubTime":"2024-09-20 22:11","pubTimestamp":1726841496,"startTime":"0","endTime":"0","summary":"北京时间2024年09月20日22时11分，Kintara Therapeutics, Inc.股票出现异动，股价大幅跳水5.23%。Kintara Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.93%。其相关个股中，Novabay Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Nutriband Inc C/Wts 涨幅较大，Galmed Pharmaceuticals Ltd.、Novabay Pharmaceuticals, Inc.、Corbus Pharmaceuticals Holdings, Inc.较为活跃，换手率分别为1492.75%、1341.84%、38.59%，振幅较大的相关个股有Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Novabay Pharmaceuticals, Inc.，振幅分别为165.20%、64.74%、50.21%。Kintara Therapeutics, Inc.公司简介：Kintara Therapeutics Inc从事针对医疗需求未得到满足的患者的新型癌症疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240920221137ab64e56e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240920221137ab64e56e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","KTRA","DMPWW","BK4139"],"gpt_icon":0},{"id":"2468505179","title":"Kintara Therapeutics, Inc.盘中异动 大幅拉升5.14%报0.184美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468505179","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468505179?lang=zh_cn&edition=full","pubTime":"2024-09-19 22:31","pubTimestamp":1726756287,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日22时31分，Kintara Therapeutics, Inc.股票出现波动，股价大幅上涨5.14%。Kintara Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.09%。其相关个股中，Exicure, Inc.、Galmed Pharmaceuticals Ltd.、Edgewise Therapeutics, Inc.涨幅较大，Galmed Pharmaceuticals Ltd.、Exicure, Inc.、Portage Biotech Inc.较为活跃，换手率分别为3613.11%、636.52%、156.60%，振幅较大的相关个股有Exicure, Inc.、Galmed Pharmaceuticals Ltd.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为81.66%、78.69%、52.97%。Kintara Therapeutics, Inc.公司简介：Kintara Therapeutics Inc从事针对医疗需求未得到满足的患者的新型癌症疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024091922312898e381e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024091922312898e381e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KTRA","BK4139","DMPWW","LENZ"],"gpt_icon":0},{"id":"2468366180","title":"Kintara Therapeutics, Inc.盘中异动 快速上涨5.76%报0.178美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468366180","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468366180?lang=zh_cn&edition=full","pubTime":"2024-09-17 23:27","pubTimestamp":1726586870,"startTime":"0","endTime":"0","summary":"北京时间2024年09月17日23时27分，Kintara Therapeutics, Inc.股票出现波动，股价大幅上涨5.76%。Kintara Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.77%。其相关个股中，Galmed Pharmaceuticals Ltd.、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Igm Biosciences, Inc.涨幅较大，Galmed Pharmaceuticals Ltd.、Allarity Therapeutics, Inc.、Hoth Therapeutics, Inc.较为活跃，换手率分别为8400.42%、674.17%、141.91%，振幅较大的相关个股有Galmed Pharmaceuticals Ltd.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ，振幅分别为151.16%、50.00%、44.44%。Kintara Therapeutics, Inc.公司简介：Kintara Therapeutics Inc从事针对医疗需求未得到满足的患者的新型癌症疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024091723275098e37cf7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024091723275098e37cf7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","DMPWW","KTRA"],"gpt_icon":0},{"id":"2461234947","title":"Kintara Therapeutics, Inc.盘中异动 早盘快速拉升5.46%报0.234美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2461234947","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461234947?lang=zh_cn&edition=full","pubTime":"2024-08-22 22:50","pubTimestamp":1724338220,"startTime":"0","endTime":"0","summary":"北京时间2024年08月22日22时50分，Kintara Therapeutics, Inc.股票出现异动，股价急速拉升5.46%。Kintara Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.59%。其相关个股中，Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Biomea Fusion, Inc.涨幅较大，Virax Biolabs Group Limited、Geovax Labs, Inc.、Revelation Biosciences, Inc.较为活跃，换手率分别为330.51%、158.51%、127.43%，振幅较大的相关个股有Revelation Biosciences Inc C/Wts 10/01/2027 、Geovax Labs Inc C/Wts 29/09/2025、居里，振幅分别为67.18%、40.84%、37.17%。Kintara Therapeutics, Inc.公司简介：Kintara Therapeutics Inc从事针对医疗需求未得到满足的患者的新型癌症疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240822225020a1d5be39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240822225020a1d5be39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DMPWW","LENZ","KTRA","BK4139"],"gpt_icon":0},{"id":"2460080002","title":"Kintara Therapeutics, Inc.盘中异动 早盘股价大涨5.03%报0.238美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460080002","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460080002?lang=zh_cn&edition=full","pubTime":"2024-08-20 21:59","pubTimestamp":1724162353,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日21时59分，Kintara Therapeutics, Inc.股票出现波动，股价快速上涨5.03%。截至发稿，该股报0.238美元/股，成交量33.3161万股，换手率0.60%，振幅3.93%。Kintara Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。Kintara Therapeutics, Inc.公司简介：Kintara Therapeutics Inc从事针对医疗需求未得到满足的患者的新型癌症疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082021591398e35885&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082021591398e35885&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KTRA","DMPWW","BK4139","LENZ"],"gpt_icon":0},{"id":"2459475653","title":"Kintara Therapeutics, Inc.盘中异动 早盘股价大涨6.26%报0.193美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459475653","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459475653?lang=zh_cn&edition=full","pubTime":"2024-08-15 22:27","pubTimestamp":1723732073,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日22时27分，Kintara Therapeutics, Inc.股票出现波动，股价快速上涨6.26%。Kintara Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.37%。其相关个股中，Cingulate Inc.、Tempest Therapeutics, Inc.、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Cingulate Inc.、Scisparc Ltd.、Altamira Therapeutics Ltd.较为活跃，换手率分别为5786.66%、1966.13%、463.81%，振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 、Tempest Therapeutics, Inc.、Cingulate Inc.，振幅分别为103.98%、75.63%、58.54%。Kintara Therapeutics, Inc.公司简介：Kintara Therapeutics Inc从事针对医疗需求未得到满足的患者的新型癌症疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081522275397198d46&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081522275397198d46&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","KTRA","DMPWW","BK4139"],"gpt_icon":0},{"id":"2458323950","title":"Kintara Therapeutics, Inc.盘中异动 下午盘急速拉升5.82%报0.180美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458323950","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458323950?lang=zh_cn&edition=full","pubTime":"2024-08-09 02:37","pubTimestamp":1723142238,"startTime":"0","endTime":"0","summary":"北京时间2024年08月09日02时37分，Kintara Therapeutics, Inc.股票出现异动，股价快速上涨5.82%。Kintara Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为3.77%。其相关个股中，Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Aldeyra Therapeutics, Inc.、Biovie Inc.涨幅较大，Conduit Pharmaceuticals Inc.、Anew Medical, Inc.、Aditxt, Inc.较为活跃，换手率分别为435.76%、299.50%、203.08%，振幅较大的相关个股有Conduit Pharmaceuticals Inc.、Oragenics Inc.、Fibrobiologics, Inc.，振幅分别为139.88%、54.41%、45.58%。Kintara Therapeutics, Inc.公司简介：Kintara Therapeutics Inc从事针对医疗需求未得到满足的患者的新型癌症疗法的开发。这两个项目是用于 GBM 的 VAL-083 和用于 CMBC 的 REM-001。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809023719aefdf529&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809023719aefdf529&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","DMPWW","KTRA"],"gpt_icon":0},{"id":"2457720798","title":"Kintara Therapeutics, Inc.盘中异动 早盘股价大跌7.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457720798","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457720798?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:32","pubTimestamp":1722864771,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时32分，Kintara Therapeutics, Inc.股票出现异动，股价急速跳水7.49%。Kintara Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.36%。其相关个股中，Zevra Therapeutics, Inc.、Alzamend Neuro, Inc.、Cns Pharmaceuticals, Inc.涨幅较大，Cns Pharmaceuticals, Inc.、Dermata Therapeutics, Inc.、Senti Biosciences, Inc.较为活跃，换手率分别为981.75%、35.48%、13.54%，振幅较大的相关个股有Vor Biopharma Inc.、Cue Biopharma, Inc.、Compass Therapeutics, Inc.，振幅分别为13.04%、12.33%、12.19%。Kintara Therapeutics, Inc.公司简介：Kintara Therapeutics Inc从事针对医疗需求未得到满足的患者的新型癌症疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213251aefd4c0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213251aefd4c0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DMPWW","LENZ","KTRA","BK4139"],"gpt_icon":0},{"id":"2455959127","title":"Kintara Therapeutics, Inc.盘中异动 快速下跌5.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2455959127","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455959127?lang=zh_cn&edition=full","pubTime":"2024-07-30 23:01","pubTimestamp":1722351661,"startTime":"0","endTime":"0","summary":"北京时间2024年07月30日23时01分，Kintara Therapeutics, Inc.股票出现异动，股价快速下跌5.73%。Kintara Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。其相关个股中，Imunon, Inc.、Cue Biopharma, Inc.、Processa Pharmaceuticals, Inc.涨幅较大，Processa Pharmaceuticals, Inc.、Imunon, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为1798.42%、1103.84%、948.20%，振幅较大的相关个股有Imunon, Inc.、Processa Pharmaceuticals, Inc.、Orgenesis Inc.，振幅分别为74.79%、55.88%、50.00%。Kintara Therapeutics, Inc.公司简介：Kintara Therapeutics Inc从事针对医疗需求未得到满足的患者的新型癌症疗法的开发。这两个项目是用于 GBM 的 VAL-083 和用于 CMBC 的 REM-001。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240730230101956d9817&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240730230101956d9817&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KTRA","DMPWW","BK4139","LENZ"],"gpt_icon":0},{"id":"2454323749","title":"Kintara Therapeutics, Inc.盘中异动 早盘急速拉升8.20%报0.235美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454323749","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454323749?lang=zh_cn&edition=full","pubTime":"2024-07-26 21:51","pubTimestamp":1722001884,"startTime":"0","endTime":"0","summary":"北京时间2024年07月26日21时51分，Kintara Therapeutics, Inc.股票出现波动，股价快速上涨8.20%。Kintara Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，Windtree Therapeutics, Inc.、Nutriband Inc C/Wts 、Celularity Inc C/Wts 16/07/2026 涨幅较大，Windtree Therapeutics, Inc.、Novabay Pharmaceuticals, Inc.、Cel-Sci Corporation较为活跃，换手率分别为3838.83%、121.06%、68.09%，振幅较大的相关个股有Windtree Therapeutics, Inc.、Cel-Sci Corporation、Promis Neurosciences Inc.，振幅分别为56.23%、49.58%、28.25%。Kintara Therapeutics, Inc.公司简介：Kintara Therapeutics Inc从事针对医疗需求未得到满足的患者的新型癌症疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072621512596820cf6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072621512596820cf6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","KTRA","BK4139","DMPWW"],"gpt_icon":0},{"id":"2453030222","title":"Kintara Therapeutics, Inc.盘中异动 股价大跌5.53%报0.231美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453030222","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453030222?lang=zh_cn&edition=full","pubTime":"2024-07-23 21:42","pubTimestamp":1721742135,"startTime":"0","endTime":"0","summary":"北京时间2024年07月23日21时42分，Kintara Therapeutics, Inc.股票出现波动，股价大幅下挫5.53%。Kintara Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.29%。其相关个股中，Azitra Inc、Adial Pharmaceuticals, Inc、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Azitra Inc、Adial Pharmaceuticals, Inc、Jaguar Health, Inc.较为活跃，换手率分别为2239.26%、1065.73%、72.06%，振幅较大的相关个股有Azitra Inc、Adial Pharmaceuticals, Inc、Anew Medical, Inc.，振幅分别为288.27%、61.32%、20.98%。Kintara Therapeutics, Inc.公司简介：Kintara Therapeutics Inc从事针对医疗需求未得到满足的患者的新型癌症疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723214215af93aa72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723214215af93aa72&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DMPWW","LENZ","KTRA","BK4139"],"gpt_icon":0},{"id":"2452615754","title":"Kintara Therapeutics, Inc.盘中异动 早盘股价大跌5.07%报0.272美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452615754","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452615754?lang=zh_cn&edition=full","pubTime":"2024-07-17 21:36","pubTimestamp":1721223369,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日21时36分，Kintara Therapeutics, Inc.股票出现波动，股价快速下挫5.07%。Kintara Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.77%。其相关个股中，Aditxt, Inc.、Aptevo Therapeutics Inc.、Longeveron Inc.涨幅较大，Aditxt, Inc.、Aptevo Therapeutics Inc.、Longeveron Inc.较为活跃，换手率分别为740.08%、531.71%、126.67%，振幅较大的相关个股有4D Molecular Therapeutics, Inc.、Ginkgo Bioworks Holdings, Inc.、Cytomed Therapeutics Limited，振幅分别为20.47%、19.03%、18.37%。Kintara Therapeutics, Inc.公司简介：Kintara Therapeutics Inc从事针对医疗需求未得到满足的患者的新型癌症疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717213609af92c9d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717213609af92c9d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","DMPWW","KTRA"],"gpt_icon":0},{"id":"2450812393","title":"Kintara Therapeutics, Inc.盘中异动 早盘股价大跌5.36%报0.261美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450812393","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450812393?lang=zh_cn&edition=full","pubTime":"2024-07-10 23:12","pubTimestamp":1720624339,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日23时12分，Kintara Therapeutics, Inc.股票出现异动，股价急速跳水5.36%。Kintara Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.34%。其相关个股中，Kazia Therapeutics Limited、Virpax Pharmaceuticals, Inc.、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Virpax Pharmaceuticals, Inc.、Soligenix, Inc.、Longeveron Inc.较为活跃，换手率分别为3612.41%、1253.77%、879.61%，振幅较大的相关个股有Kazia Therapeutics Limited、Revolution Medicines Inc C/Wts 17/12/2026 、Virpax Pharmaceuticals, Inc.，振幅分别为328.13%、133.16%、119.83%。Kintara Therapeutics, Inc.公司简介：Kintara Therapeutics Inc从事针对医疗需求未得到满足的患者的新型癌症疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407102312199681b931&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407102312199681b931&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DMPWW","BK4139","KTRA","LENZ"],"gpt_icon":0},{"id":"2449341705","title":"Kintara Therapeutics, Inc.盘中异动 快速拉升11.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449341705","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449341705?lang=zh_cn&edition=full","pubTime":"2024-07-08 21:31","pubTimestamp":1720445505,"startTime":"0","endTime":"0","summary":"北京时间2024年07月08日21时31分，Kintara Therapeutics, Inc.股票出现波动，股价急速上涨11.00%。Kintara Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。其相关个股中，Morphic Holding, Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Kineta, Inc.涨幅较大，Virpax Pharmaceuticals, Inc.、Cero Therapeutics Holdings, Inc.、Kineta, Inc.较为活跃，换手率分别为155.28%、129.95%、105.63%，振幅较大的相关个股有Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Cero Therapeutics Holdings, Inc.、IDEAYA生物科学，振幅分别为30.65%、16.33%、11.30%。Kintara Therapeutics, Inc.公司简介：Kintara Therapeutics Inc从事针对医疗需求未得到满足的患者的新型癌症疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407082131459590a82e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407082131459590a82e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","DMPWW","KTRA"],"gpt_icon":0},{"id":"2448918162","title":"Kintara Therapeutics, Inc.盘中异动 股价大涨10.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448918162","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448918162?lang=zh_cn&edition=full","pubTime":"2024-07-01 21:32","pubTimestamp":1719840730,"startTime":"0","endTime":"0","summary":"北京时间2024年07月01日21时32分，Kintara Therapeutics, Inc.股票出现波动，股价大幅拉升10.33%。Kintara Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。其相关个股中，Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Senti Biosciences, Inc.涨幅较大，Tonix Pharmaceuticals Holding Corp.、Senti Biosciences, Inc.、Geovax Labs, Inc.较为活跃，换手率分别为74.68%、68.44%、12.54%，振幅较大的相关个股有Anew Medical Inc C/Wts 21/06/2029 、Seastar Medical Holding Corporation、Neximmune, Inc.，振幅分别为28.45%、12.52%、10.87%。Kintara Therapeutics, Inc.公司简介：Kintara Therapeutics Inc从事针对医疗需求未得到满足的患者的新型癌症疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407012132109eed3a44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407012132109eed3a44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DMPWW","LENZ","KTRA","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kintara.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":-0.0439},{"period":"6month","weight":0.2821},{"period":"1year","weight":-0.3629},{"period":"ytd","weight":0.27}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Kintara Therapeutics, Inc.是一家内华达州公司，成立于2009年6月24日，名称为Berry Only，Inc。该公司是一家临床阶段的生物制药公司。Kintara致力于为医疗需求未得到满足的患者开发新型癌症疗法。Kintara公司正在开发两种晚期疗法，以降低风险，满足明确的未满足的医疗需求。这两个项目分别是VAL-083治疗胶质母细胞瘤（GBM）和REM-001治疗皮肤转移性乳腺癌（CMBC）。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.077817},{"month":2,"riseRate":0.125,"avgChangeRate":-0.104771},{"month":3,"riseRate":0.25,"avgChangeRate":-0.042889},{"month":4,"riseRate":0.25,"avgChangeRate":-0.056005},{"month":5,"riseRate":0.625,"avgChangeRate":1.371723},{"month":6,"riseRate":0.5,"avgChangeRate":-0.011708},{"month":7,"riseRate":0.375,"avgChangeRate":-0.030517},{"month":8,"riseRate":0.444444,"avgChangeRate":-0.105627},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.105678},{"month":10,"riseRate":0.444444,"avgChangeRate":-0.102004},{"month":11,"riseRate":0.375,"avgChangeRate":-0.094725},{"month":12,"riseRate":0.25,"avgChangeRate":-0.134944}],"exchange":"NASDAQ","name":"Kintara Therapeutics, Inc.","nameEN":"Kintara Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Kintara Therapeutics, Inc.(KTRA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Kintara Therapeutics, Inc.(KTRA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Kintara Therapeutics, Inc.,KTRA,Kintara Therapeutics, Inc.股票,Kintara Therapeutics, Inc.股票老虎,Kintara Therapeutics, Inc.股票老虎国际,Kintara Therapeutics, Inc.行情,Kintara Therapeutics, Inc.股票行情,Kintara Therapeutics, Inc.股价,Kintara Therapeutics, Inc.股市,Kintara Therapeutics, Inc.股票价格,Kintara Therapeutics, Inc.股票交易,Kintara Therapeutics, Inc.股票购买,Kintara Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Kintara Therapeutics, Inc.(KTRA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Kintara Therapeutics, Inc.(KTRA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况